Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS).

ref CC BY-NC issue-copyright-statement © The Author(s) 2022 Key Points Introduction The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; coronavirus disease 2019 [COVID-19]) pandemic has lasted for more than 2 years, and the number of cumulative confirmed cases continues to grow, with an increasing trend that has led to the worst modern global emergency [ 1 ].

also in 63,971 other papers